City
Epaper

New technique identifies pathological abnormalities in motor neurone disease

By IANS | Updated: August 8, 2024 16:25 IST

New Delhi, Aug 8 UK researchers on Thursday informed of developing a technique to identify pathological abnormalities associated ...

Open in App

New Delhi, Aug 8 UK researchers on Thursday informed of developing a technique to identify pathological abnormalities associated with motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS).

The findings by researchers from the University of Birmingham in the UK could lead to a better understanding of the brain changes that cause MND and potentially pave the way for new treatments.

MND is a debilitating muscle-wasting condition caused by the brain’s motor neurons failing to send signals to muscles, resulting in weakness. Currently, there is no cure.

The new technique, called native ambient mass spectrometry (NAMS), allows researchers to examine specific proteins in their native state directly from brain and spinal cord tissue samples. This method provides unprecedented detail in studying the structure of proteins concerning their location within the tissue.

The researchers identified a metal deficiency in a protein known as SOD1. They demonstrated that this deficiency causes the protein to accumulate in specific regions of the brain and spinal cord in mice with MND. While SOD1 has previously been implicated in motor neurone disease, this is the first time detailed molecular imaging has shown how metal-deficient versions of the protein accumulate in affected areas.

“This approach is the first to show that this form of SOD1 correlates with the pathology of motor neurone disease,” said Helen Cooper, lead researcher at Birmingham’s School of Biosciences.

“It’s a very early step towards finding treatments for MND and is also an exciting new route for understanding the molecular basis of other diseases in unprecedented detail,” Cooper added.

MND is a relatively rare condition that is most common in people over 50. However, it can affect adults of any age.

The lifetime risk of a person developing MND is one in 300.

The next steps for the researchers include testing whether the same imbalances are present in human tissue samples and attempting to treat the imbalance in mice using available drug compounds.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentKerala rapper Vedan arrested after ganja seized from his flat

CricketKevin Pietersen backs KL Rahul for India T20I recall, says, "I would bat KL at....."

InternationalPakistan scrambles to mitigate Trump tariffs, to send delegation to US

InternationalIndian Naval Officer pays courtesy visit to Maldives defence officials

InternationalIndia, France sign intergovernmental agreement on 26 Rafale Jets for Indian Navy

Health Realted Stories

HealthJabalpur’s newborn gets life-saving heart treatment under Rashtriya Bal Swasthya Karyakram

HealthCovid-19 vaccines have no lasting impact on metabolic health: Study

HealthNew tech using body fluids to make accurate diagnosis of arthritis in just 10 minutes

HealthNew biosensor platform to detect preeclampsia in pregnant women in 30 minutes

HealthUnion Minister hails launch of Ayushman Vay Vandana Card in Delhi, elderly thank govt